ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present at Annual JPMorgan Healthcare Conference
|
|
KentJC
|
104 |
58K |
16 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
104
|
58K
|
16
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
7 |
09/01/24 |
09/01/24 |
Charts
|
31K
|
15M
|
7
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The dearly departed
|
|
KentJC
|
37 |
14K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
37
|
14K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
10 |
30/11/23 |
30/11/23 |
Charts
|
31K
|
15M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
17 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
13K
|
6.2M
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
5 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
13K
|
6.2M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
KentJC
|
228 |
93K |
11 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
93K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
KentJC
|
228 |
93K |
6 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
93K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
KentJC
|
228 |
93K |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
93K
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
11 |
08/11/23 |
08/11/23 |
Charts
|
31K
|
15M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
KentJC
|
228 |
93K |
36 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
93K
|
36
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
KentJC
|
264 |
98K |
42 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
264
|
98K
|
42
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Ceasing to be a substantial holder
|
|
KentJC
|
43 |
18K |
7 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
43
|
18K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Ceasing to be a substantial holder
|
|
KentJC
|
43 |
18K |
21 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
43
|
18K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
KentJC
|
103 |
46K |
2 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
103
|
46K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: ALA: Europe Patent granted for iNKT Cell Therapy Platform
|
|
KentJC
|
55 |
30K |
10 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
55
|
30K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
KentJC
|
153 |
67K |
10 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
153
|
67K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: OGTR grants VAXINIA DIR licence allowing trial expansion
|
|
KentJC
|
137 |
74K |
7 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
137
|
74K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: OGTR grants VAXINIA DIR licence allowing trial expansion
|
|
KentJC
|
137 |
74K |
45 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
137
|
74K
|
45
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr Jakob Dupont as Non-Executive Director
|
|
KentJC
|
34 |
20K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
34
|
20K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr Jakob Dupont as Non-Executive Director
|
|
KentJC
|
34 |
20K |
4 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
34
|
20K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Ann: HREC decision to not approve Phase I Clinical Trial
|
|
KentJC
|
96 |
37K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
96
|
37K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Ann: HREC decision to not approve Phase I Clinical Trial
|
|
KentJC
|
96 |
37K |
2 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
96
|
37K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Ann: HREC decision to not approve Phase I Clinical Trial
|
|
KentJC
|
96 |
37K |
2 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
96
|
37K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Ann: HREC decision to not approve Phase I Clinical Trial
|
|
KentJC
|
96 |
37K |
0 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
96
|
37K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: HREC decision to not approve Phase I Clinical Trial
|
|
KentJC
|
96 |
37K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
96
|
37K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
6 |
31/08/22 |
31/08/22 |
Charts
|
31K
|
15M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
KentJC
|
22K |
11M |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
22K
|
11M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
|
|
KentJC
|
77 |
47K |
7 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
77
|
47K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
|
|
KentJC
|
77 |
47K |
57 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
77
|
47K
|
57
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
18 |
05/08/22 |
05/08/22 |
Charts
|
31K
|
15M
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
KentJC
|
22K |
11M |
3 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
22K
|
11M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
13K
|
6.2M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results
|
|
KentJC
|
32 |
18K |
31 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
32
|
18K
|
31
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
85 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
13K
|
6.2M
|
85
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
61 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
13K
|
6.2M
|
61
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
12 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
13K
|
6.2M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
17 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
13K
|
6.2M
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
19 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
13K
|
6.2M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
41 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
13K
|
6.2M
|
41
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
3 |
01/02/22 |
01/02/22 |
Charts
|
31K
|
15M
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
0 |
01/02/22 |
01/02/22 |
Charts
|
31K
|
15M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
7 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
13K
|
6.2M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
16 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
13K
|
6.2M
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
23 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
13K
|
6.2M
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
1 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
13K
|
6.2M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
21 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
13K
|
6.2M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
KentJC
|
13K |
6.2M |
18 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
13K
|
6.2M
|
18
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
KentJC
|
31K |
15M |
33 |
21/12/21 |
21/12/21 |
Charts
|
31K
|
15M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 2A and IMUOB Option Underwriting Agreement
|
|
KentJC
|
42 |
20K |
15 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
42
|
20K
|
15
|
|